Free Trial

Rockwell Medical (RMTI) Competitors

Rockwell Medical logo
$1.10 +0.01 (+0.92%)
Closing price 04:00 PM Eastern
Extended Trading
$1.12 +0.01 (+1.36%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RMTI vs. RSLS, ABT, ISRG, BSX, SYK, MDT, BDX, EW, IDXX, and RMD

Should you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), and ResMed (RMD). These companies are all part of the "health care equipment" industry.

Rockwell Medical vs. Its Competitors

Rockwell Medical (NASDAQ:RMTI) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

Rockwell Medical has higher revenue and earnings than ReShape Lifesciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rockwell Medical$101.49M0.37-$480KN/AN/A
ReShape Lifesciences$8.01M0.95-$7.13M-$193.23-0.02

Rockwell Medical has a net margin of -0.27% compared to ReShape Lifesciences' net margin of -48.26%. Rockwell Medical's return on equity of -0.90% beat ReShape Lifesciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Rockwell Medical-0.27% -0.90% -0.47%
ReShape Lifesciences -48.26%-251.90%-59.49%

In the previous week, Rockwell Medical had 1 more articles in the media than ReShape Lifesciences. MarketBeat recorded 1 mentions for Rockwell Medical and 0 mentions for ReShape Lifesciences. ReShape Lifesciences' average media sentiment score of 1.87 beat Rockwell Medical's score of 0.94 indicating that ReShape Lifesciences is being referred to more favorably in the news media.

Company Overall Sentiment
Rockwell Medical Positive
ReShape Lifesciences Very Positive

Rockwell Medical currently has a consensus price target of $4.00, suggesting a potential upside of 263.64%. Given Rockwell Medical's stronger consensus rating and higher probable upside, analysts clearly believe Rockwell Medical is more favorable than ReShape Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rockwell Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
ReShape Lifesciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 22.1% of ReShape Lifesciences shares are held by institutional investors. 3.6% of Rockwell Medical shares are held by company insiders. Comparatively, 0.0% of ReShape Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Rockwell Medical has a beta of 1.57, meaning that its stock price is 57% more volatile than the S&P 500. Comparatively, ReShape Lifesciences has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500.

Summary

Rockwell Medical beats ReShape Lifesciences on 13 of the 15 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RMTI vs. The Competition

MetricRockwell MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$37.25M$10.25B$5.54B$9.41B
Dividend YieldN/A2.06%3.75%4.03%
P/E RatioN/A16.5828.0119.82
Price / Sales0.3730.02433.8198.96
Price / Cash8.6222.3936.1658.27
Price / Book1.093.578.125.65
Net Income-$480K$235.43M$3.25B$257.91M
7 Day Performance-2.65%-1.67%0.97%2.09%
1 Month Performance17.02%2.91%7.36%11.13%
1 Year Performance-42.11%-16.44%31.31%18.40%

Rockwell Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMTI
Rockwell Medical
3.9035 of 5 stars
$1.10
+0.9%
$4.00
+263.6%
-46.2%$37.25M$101.49M0.00300News Coverage
RSLS
ReShape Lifesciences
N/A$2.38
+0.4%
N/A-99.2%$5.69M$8.01M-0.0150
ABT
Abbott Laboratories
4.988 of 5 stars
$133.62
-0.6%
$142.61
+6.7%
+15.3%$232.48B$41.95B17.33114,000Trending News
Earnings Report
Ex-Dividend
Analyst Forecast
ISRG
Intuitive Surgical
4.7015 of 5 stars
$534.71
-1.8%
$588.95
+10.1%
+21.1%$191.65B$8.35B78.4015,638Positive News
Upcoming Earnings
Analyst Revision
BSX
Boston Scientific
4.6219 of 5 stars
$103.75
-0.5%
$116.09
+11.9%
+35.1%$153.49B$16.75B75.7353,000Trending News
Upcoming Earnings
SYK
Stryker
4.7787 of 5 stars
$392.26
-0.8%
$427.30
+8.9%
+16.3%$149.72B$22.60B53.0153,000Positive News
MDT
Medtronic
4.6379 of 5 stars
$87.73
-0.7%
$97.87
+11.6%
+10.2%$112.52B$33.54B24.2395,000Positive News
Analyst Forecast
Analyst Revision
BDX
Becton, Dickinson and Company
4.7555 of 5 stars
$172.92
-1.8%
$219.22
+26.8%
-22.8%$49.56B$20.18B33.0074,000Analyst Revision
EW
Edwards Lifesciences
4.3727 of 5 stars
$76.64
-0.2%
$80.20
+4.6%
-12.7%$44.96B$5.44B10.9515,800Positive News
Upcoming Earnings
Analyst Forecast
IDXX
IDEXX Laboratories
3.6718 of 5 stars
$545.56
-0.3%
$558.11
+2.3%
+4.5%$43.87B$3.90B50.4211,000Positive News
Analyst Forecast
Analyst Revision
RMD
ResMed
4.2677 of 5 stars
$256.16
-0.3%
$259.33
+1.2%
+24.5%$37.56B$4.69B28.759,980Positive News
Analyst Upgrade
Analyst Revision

Related Companies and Tools


This page (NASDAQ:RMTI) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners